This is a working overview of Visceral adipose tissue, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-12-21. Anything still debated is marked as such rather than presented as settled.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide | GHRH analog family |
| Residue count | 44 amino acids | Matches human GHRH(1-44) backbone |
| N-terminal group | trans-3-hexenoyl | Main structural difference from native hormone |
| Appearance | White to off-white powder | Lyophilized solid form |
| Solubility class | Freely soluble in water | Peptide character; less soluble in organic solvents |
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
== Raids and arrests == In July 2022, the Central Office for the Repression of Corruption (French: Office central pour la répression de la corruption, OCRC, Dutch: Centrale Dienst voor de Bestrijding van Corruptie), a unit of the Belgian Federal Police, opened an investigation into an alleged criminal organisation. The investigation was led by Michel Claise, an investigating magistrate who works with the GRECO (Group of States against Corruption). On 9 December 2022, acting on the investigation, Belgian police conducted 20 raids at 19 different addresses across Brussels in connection with the conspiracy, resulting in eight arrests across Belgium and Italy. The homes and offices of the suspects were searched, including offices within the European Parliament buildings in Brussels. As required by the Belgian Constitution, the President of the European Parliament, Roberta Metsola, had to return from her home in Malta to be present during searches of the properties of Eva Kaili and Marc Tarabella, both of whom who held parliamentary immunity as MEPs. The first arrest took place at Sofitel hotel at Place Jourdan, Brussels, where investigators arrested Eva Kaili's father, Alexandros. He was found with a suitcase containing "several hundred thousand euros" while attempting to flee. Investigating judge Michel Claise deemed the arrest in flagrante delicto, or caught in the act, which resulted in Kaili losing her parliamentary immunity, enabling investigators to search her property.
Nidanas 1, 2 and 3 which cast beings downward into the whirl of transmigration Nidanas 4 to 7 represent what undergoes transmigration, "the aspects of the person undergoing phenomenal life" (Wayman). Nidanas 8, 9, 10 produce new karma Nidanas 11 and 12 are the fruits or results of karma produced previously According to Gombrich, the "contorted" three lives interpretation is rendered unnecessary by the analysis provided by Jurewicz and other scholars which show that the 12 link chain is a composite list.
These organostannanes are also stable to both air and moisture, and many of these reagents either are commercially available or can be synthesized from literature precedent. However, these tin reagents tend to be highly toxic. X is typically a halide, such as Cl, Br, or I, yet pseudohalides such as triflates and sulfonates and phosphates can also be used. Several reviews have been published.
Increased blood CRP levels were higher in people with avian flu H7N9 compared to those with H1N1 (more common) influenza, with a review reporting that severe H1N1 influenza had elevated CRP. In 2020, people infected with COVID-19 in Wuhan, China, had elevated CRP. MedlinePlus Encyclopedia: C-reactive protein Inflammation, Heart Disease and Stroke: The Role of C-Reactive Protein (American Heart Association) C-Reactive+Protein at the U.S. National Library of Medicine Medical Subject Headings (MeSH) CRP: analyte monograph - The Association for Clinical Biochemistry and Laboratory Medicine George Vrousgos, N.D. - Southern Cross University Archived 2020-02-18 at the Wayback Machine Human CRP genome location and CRP gene details page in the UCSC Genome Browser. Overview of all the structural information available in the PDB for UniProt: P02741 (C-reactive protein) at the PDBe-KB.
Sources: en.wikipedia.org
== Abuse == The abuse of exogenous insulin carries with it an attendant risk of hypoglycemic coma and death when the amount used is in excess of that required to handle ingested carbohydrate. Acute risks include brain damage, paralysis, and death. Symptoms may include dizziness, weakness, trembling, palpitations, seizures, confusion, headache, drowsiness, coma, diaphoresis and nausea. All persons with overdoses should be referred for medical assessment and treatment, which may last for hours or days. Data from the US National Poison Data System (2013) indicates that 89.3% of insulin cases reported to poison centers are unintentional, as a result of therapeutic error. Another 10% of cases are intentional, and may reflect attempted suicide, abuse, criminal intent, secondary gain or other unknown reasons. Hypoglycemia that has been induced by exogenous insulin can be chemically detected by examining the ratio of insulin to C-peptide in peripheral circulation. It has been suggested that this type of approach could be used to detect exogenous insulin abuse by athletes.
=== Characterization of interfaces and surfactant layers === Interfacial and surface tension can be characterized by classical methods such as the -pendant or spinning drop method. Dynamic surface tensions, i.e. surface tension as a function of time, can be obtained by the maximum bubble pressure apparatus The structure of surfactant layers can be studied by ellipsometry or X-ray reflectivity. Surface rheology can be characterized by the oscillating drop method or shear surface rheometers such as double-cone, double-ring or magnetic rod shear surface rheometer.
In the 1950s, the French established secret commando groups based on loyal Montagnard ethnic minorities referred to as "partisans" or "maquisards", called the Groupement de Commandos Mixtes Aéroportés (Composite Airborne Commando Group or GCMA), later renamed Groupement Mixte d'Intervention (GMI, or Mixed Intervention Group), directed by the SDECE counter-intelligence service. The SDECE's "Service Action" GCMA used both commando and guerrilla techniques and operated in intelligence and secret missions from 1950 to 1955. Declassified information about the GCMA includes the name of its commander, famous Colonel Roger Trinquier, and a mission on April 30, 1954, when Jedburgh veteran Captain Sassi led the Meo partisans of the GCMA Malo-Servan in Operation Condor during the siege of Dien Bien Phu. In 1951, Adjutant-Chief Vandenberghe from the 6th Colonial Infantry Regiment (6e RIC) created the "Commando Vanden" (aka "Black Tigers", aka "North Vietnam Commando #24") based in Nam Định. Recruits were volunteers from the Thổ people, Nùng people and Miao people. This commando unit wore Việt Minh black uniforms to confuse the enemy and used techniques of the experienced Bo doi (Bộ đội, regular army) and Du Kich (guerrilla unit). Việt Minh prisoners were recruited in POW camps. The commando was awarded the Croix de Guerre des TOE with palm in July 1951; however, Vandenberghe was betrayed by a Việt Minh recruit, commander Nguien Tinh Khoi (308th Division's 56th Regiment), who assassinated him (and his Vietnamese fiancée) with external help on the night of January 5, 1952.
Papers suggest that the lack of cell cycle arrest and apoptosis gives more cells the chance to be reprogrammed. Decreased levels of p53 were also shown to be a crucial aspect of blastema formation in the legs of salamanders. p53 regulation is very important in acting as a barrier between stem cells and a differentiated stem cell state, as well as a barrier between stem cells being functional and being cancerous.
Contamination has also been seen in water wells and other sources of drinking water. This contamination is seen in US, United Kingdom, Germany, Japan, and Canada, but information from most developing countries is nearly nonexistent. The lack of information on PFAS contamination in developing countries, especially those in Africa, are due to structural socioeconomic inequality and lack of access to the expensive laboratory capabilities required for PFAS quantification.
Sources: en.wikipedia.org
== N == N terminus - N-acetylhexosamine 1-dehydrogenase - N-acylmannosamine 1-dehydrogenase - N-formylmethionylaminoacyl-tRNA deformylase - N-isopropylammelide isopropylaminohydrolase - Na+-transporting two-sector ATPase - NADH:ubiquinone reductase (Na+-transporting) - native gel - nematode Her-1 - neolactotetraosylceramide alpha-2,3-sialyltransferase - nested PCR - neurofibromatosis - NH41 - nick (DNA) - nick translation - NIDDM1 - Niemann-Pick disease, type C - nitrate-transporting ATPase - NMNH (Dihydronicotinamide Mononucleotide) - non-coding DNA - non-coding strand - non-directiveness - nonconservative substitution - nonpolar-amino-acid-transporting ATPase - nonsense codon - nonsense mutation - nontranslated RNA - Northern blot - NT - nuclear run-on - nuclease - nuclease protection assay - nucleoplasmin ATPase - nucleoside - nucleoside-triphosphate diphosphatase - nucleotide - Nucleotide universal IDentifier - nucleus -
=== No development reported === ACH-36 – undefined mechanism of action [22] Alprazolam sublingual – GABAA receptor positive allosteric modulator and benzodiazepine [23] Antalarmin (CP-154526) – corticotropin-releasing hormone (CRH) inhibitor [24] Buspirone controlled release (Buspirone ER) – serotonin 5-HT1A receptor partial agonist and other actions [25] BW-723C86 – serotonin 5-HT2B and 5-HT2C receptor agonist [26] Cannabidiol dry powder inhalation (RLS-103) – cannabinoid receptor modulator and other actions [27] Darigabat (CVL-865; PF-06372865; PF-6372865) – GABAA receptor positive allosteric modulator [28] Divaplon (RU-32698) – GABAA receptor positive allosteric modulator and nonbenzodiazepine/imidazolpyrimidine [29] Fananserin (RP-62203) – serotonin 5-HT2A receptor antagonist and dopamine D4 receptor antagonist [30] FR260010 (FR-260010) – serotonin 5-HT2C receptor antagonist [31] [32] GSK-588045 (GSK588045) – serotonin 5-HT1A, 5-HT1B, and 5-HT1D receptor antagonist [33] GSK-1360707 – serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) [34] GT-001 – GABAA receptor positive allosteric modulator [35] Guanfacine extended release (Connexyn; Intuniv; Intuniv XR; S-877503; SHP-503; SPD-503) – α2-adrenergic receptor agonist [36] Itriglumide (CR-2945) – cholecystokinin B (CCKB) receptor antagonist [37] Lohocla-201 (Kindolor) – various actions [38] LY-293284 – serotonin 5-HT1A receptor agonist [39] NMRA-511 (BTRX-323511; NMRA-323511) – vasopressin V1A receptor antagonist [40] Paroxetine (Aropax; BRL-29060; Deroxat; Divarius; FG-7051; Frosinor; Motivan; NNC-207051; Paxil; Seroxat; SI-211103; Tagonis) – selective serotonin reuptake inhibitor (SSRI) [41] Psilocybin (MYCO-001; MYCO-003) – non-selective serotonin receptor agonist and psychedelic hallucinogen [42] PT-00114 (PT100114) – corticotropin-releasing hormone (CRH) inhibitor [43] Research programme: allosteric modulators - Addex Therapeutics – various actions [44] Research programme: AMPA receptor agonists - RespireRx (ampakines; CX compounds) – AMPA receptor agonists and brain-derived neurotrophic factor (BDNF) stimulants [45] Research programme: anxiety and neurological disorder therapeutics - AstraZeneca – various actions [46] Research programme: cannabis-based therapeutics - Skye Bioscience – cannabinoid receptor agonists [47] Research programme: neuropeptide S receptor modulators - Pfizer (WYE-198232) – neuropeptide receptor agonists [48] Research programme: oxytocin receptor agonist - Wyeth – oxytocin receptor agonists [49] RGH-618 – metabotropic glutamate mGlu5 receptor negative allosteric modulator [50] Riluzole (PK-26124; Rilutek; RP-54274) – various actions [51] Risperidone (JNJ-410397-AAA; R-64766; R064766; Risperdal; Risperdal Consta; Risperdal Depot) – atypical antipsychotic (non-selective monoamine receptor modulator) [52] Saripidem (SL-850274) – GABAA receptor positive allosteric modulator and nonbenzodiazepine/imidazopyridine [53] SB-242084 (SB242084) – serotonin 5-HT2C receptor antagonist [54] SRX-246 (API-246) – vasopressin V1A receptor antagonist [55] SYT-510 – anandamide reuptake inhibitor [56] Tebideutorexant (JNJ-3215; JNJ-61393215; Orexin-1) – orexin OX1 receptor antagonist [57] WAY-100135 – serotonin 5-HT1A receptor antagonist [58] Ziprasidone (CP-88059-01; CP-88059-1; Geodon; ME-2112; RQ-00000003; Zeldox) – atypical antipsychotic (non-selective monoamine receptor modulator) [59]
Work on the settlement began in 1843 and it became the capital in July 1845. It was named after Lord Stanley, Secretary of State for War and the Colonies at the time. In 1849, 30 married Chelsea Pensioners were settled there to help with the defence of the islands and to develop the new settlement. The settlement soon grew as a deep-water port, specialising at first in ship repairs; before the construction of the Panama Canal, Port Stanley was a major repair stop for ships travelling through the Straits of Magellan. The rough waters and intense storms found at the tip of the continent forced many ships to Stanley Harbour, and the ship repair industry helped to drive the island economy. Later it became a base for whaling and sealing in the South Atlantic and Antarctic. Later still it was an important coaling station for the Royal Navy. This led to ships based here being involved in the Battle of the Falkland Islands in the First World War, and the Battle of the River Plate in the Second World War. Landslides caused by excessive peat cutting destroyed part of the town in 1879 and again in 1886, which killed two people. At about midnight on 29 November 1878 a black moving mass, several feet high, was moving forwards at a rate of 4 miles per hour (6.4 km/h) or 5 miles per hour (8.0 km/h). The next morning the town was cut in two; the only way to travel between the two parts was by boat. During the Second World War, a hulk in Stanley Harbour was used for interning the British Fascist and Mosleyite Jeffrey Hamm.
Silica monoliths, on the other hand, are created in a mold, undergo a significant amount of shrinkage, and are then clad in a polymeric shrink tubing like PEEK (polyetheretherketone) to reduce wall effects. This method limits the size of columns that can be produced to less than 15 cm long, and though standard analytical inner diameters are readily achieved, there is currently a trend in developing nanoscale capillary and prep scale silica monoliths.
Sources: en.wikipedia.org
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.
It blocks the amino-terminal degradation step that limits native GHRH. The addition extends how long the peptide survives in plasma without removing its ability to activate the receptor.
The chain contains 44 amino acid residues. It matches the human GHRH(1-44) sequence apart from the amino-terminal modification.
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.